Upstream Bio, Inc. (UPB)
5.365
+0.02
(+0.47%)
USD |
NASDAQ |
Sep 21, 16:00
5.37
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio EPS Diluted (TTM) : -2.886 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.886 |
| March 31, 2026 | -2.902 |
| December 31, 2025 | -2.663 |
| September 30, 2025 | -2.284 |
| Date | Value |
|---|---|
| June 30, 2025 | -2.051 |
| March 31, 2025 | -1.307 |
| December 31, 2024 | -0.7989 |
| September 30, 2024 | -0.3924 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Sutro Biopharma, Inc. | -17.41 |
| Compass Therapeutics, Inc. | -0.4025 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |